Mitsubishi Tanabe Pharma Corporation

Munetomo Matsuda

Tomohiro Takahashi

Tomoyuki Omura

Kouji Hayashi

Tadashi Miyazawa

Tetsuo Hayama

Kenjiro Takayanagi

Kenjirou Takayanagi

Kazuhiko Ozaki

Tetsurou Nishimura

An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.

Edaravone suspension for oral administration

The present invention provides and a plastic container and multilayered films, which comprises a heat-sealable seal layer, a cyclic polyolefin layer, and an outermost layer, wherein the seal layer comprises polypropylene, the cyclic polyolefin layer comprises a cyclic polyolefin polymer or a cyclic polyolefin copolymer, and the outermost layer comprises a layer containing polypropylene, and which further comprises a resin composition layer comprises a blended product of a propylene polymer and a styrene elastomer. The plastic container of the present invention can suppresses a reduction in the medicament content of a liquid-state medicament and is excellent in terms of shock resistance, handling ability during the filling of the container with the medicament, and the moldability and transparency of the container.

Plastic container comprising cyclic polyolefin layer

Growing community of inventors

Osaka, Japan

Munetomo Matsuda